New hope for breast cancer patients: drug may prevent dangerous drop in blood cells
Disease control
Not yet recruiting
This study tests whether the drug hetrombopag can prevent or reduce low platelet counts caused by a type of breast cancer treatment called ADC drugs. It involves 72 breast cancer patients who are about to start or have already had low platelets from these drugs. The goal is to se…
Phase: PHASE2 • Sponsor: Fujian Cancer Hospital • Aim: Disease control
Last updated Apr 26, 2026 19:39 UTC